News You Can Use August 14, 2021

This is a publication to keep you informed of issues and events pertaining to the osteopathic profession in Washington State. We invite you to submit topics or articles of interest to your colleagues for consideration. Submissions may be emailed to executivedirector@woma.org

Send Your Comments Telehealth Report & Recommendations Your feedback is requested on the Bree Collaborative's draft Telehealth Report & Recommendations Comments must be received by 5pm Friday, August 27th Telehealth Recommendations Please read the recommendations here and provide feedback here. This guideline is directed to all those who provide, received, and pay for health care and includes specific action steps following our framework for telehealth quality of appropriateness, person-centered interactions, and measurement and follow-up for: Health care providers, Delivery sites and systems, Health insurance plans, Those receiving care (consumers), and Employer health care purchasers. We hope that this guideline is useful to our health care ecosystem and people being served as we navigate the opportunities for care improvement. For more information or to give additional feedback, please email bree@qualityhealth.org or call (206) 204-7377. Thank. you for your participation in this effort to improve health care quality, outcomes affordability, and equity in Washington State.

CR-101 Alert: Rule modification Chapter 246-101 WAC, Notifiable Conditions The Washington State Board of Health (Board) filed a CR-101 Preproposal Statement of Inquiry for Chapter 246-101 WAC, Notifiable Conditions, as WSR 21-15-105 on July 23, 2021. The CR-101 announces to the public that the Board is considering revising the rule to: Establish and clarify reporting requirements for COVID-19 for health care providers, health care facilities, laboratories, and local health jurisdictions, consistent with the Board’s emergency rules Clarify the instances in which a health care provider or facility must report a notifiable condition to a local health jurisdiction or the Department of Health Make editorial revisions as necessary to improve clarity and usability COVID19_WSR2115105SBOHNotifiablecondtions101final-20212007.pdf Previously, the Board adopted amendments to the Notifiable Conditions rule at their March 10, 2021 meeting. These amendments go into effect on January 31, 2022. More information on these amendments can be found on this web page. The Board will be using this distribution list to keep interested parties updated and to share information about opportunities to be engaged in the rule change. Please forward this message to others who may be interested in receiving these emails. Please visit the rule web page for more information about the rule revision or you can contact Kaitlyn Donahoe or Samantha Pskowski at the State Board of Health.

Monoclonal Antibody Treatments for COVID-19 Dear Health Care Providers, Treatment options for COVID-19 have advanced and we now have more tools –including monoclonal antibodies— to prevent hospitalization and death. Monoclonal antibodies are laboratory-made proteins used to fight active COVID-19 infections. They provide protection when a person’s immune system cannot or has not had time to respond, neutralizing or killing SARS-CoV-2. Here’s what you need to know: A growing body of research has shown that monoclonal antibody treatments can prevent severe illness, hospitalization, and death from COVID-19. The treatments are now easier to administer because they can be given subcutaneously, not only through an IV infusion. The National Institutes of Health and the Infectious Disease Society of America both recommend monoclonal antibodies as part of their COVID-19 treatment guidelines. Providers should consider using monoclonal antibodies to treat anyone who meets eligibility criteria and is at risk of developing severe COVID-19 illness. For more information, contact Ezra.Stark@doh.wa.gov or see our guidance for the use of monoclonal antibody products to treat COVID-19. Bob Lutz, MD, MPH Medical Advisor, COVID-19 Read more details in the attached Monoclonal Antibodies Provider Letter. Monoclonal Antibodies Provider Letter Final.pdf

Provide Your Feedback Here

Registration Still Open!

One Day. Eight CME Credits. It's Nothing Fancy. It's Simply CME. Earn 8 AOA & AMA CME Credits All events can be viewed LIVE and/or ON-DEMAND for at least 45 days post-event! Members of any sponsoring state association will enjoy a discounted rate of $215 when they register before the live event! Post-event and non-member registration is $275 LEARN MORE

August 21 Topics More details coming SOON! ECG Cases-The Game is Afoot Trauma-Informed Care in Practice Abdominal Pain: The Great Clinic Frontier Don't be Rash! Tips to Effectively Manage Pediatric Rashes This Too Shall Pass: Kidney Stone Treatment and Prevention Are the Kids Alright? An Osteopathic Approach to Pediatric Mental Health Evaluation and Management of Dementia Sleep Apnea and Other Pulmonary Issues for Primary Care

Website    About Us    Advocacy    Careers    Communications

The Washington Osteopathic Medical Association

‌